Form 8-K - Current report:
SEC Accession No. 0001140361-25-000132
Filing Date
2025-01-03
Accepted
2025-01-03 08:30:17
Documents
18
Period of Report
2024-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20039922x1_8k.htm   iXBRL 8-K 36921
2 EXHIBIT 4.1 ny20038822x2_ex4-1.htm EX-4.1 70033
3 EXHIBIT 99.1 ny20038822x2_ex99-1.htm EX-99.1 19678
7 ny20038822x2ex99-1_image01.jpg GRAPHIC 2335
8 ny20038822x2ex99-1_image02.jpg GRAPHIC 1583
9 ny20038822x2ex99-1_image03.jpg GRAPHIC 5355
  Complete submission text file 0001140361-25-000132.txt   296297

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bngo-20241231.xsd EX-101.SCH 4004
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bngo-20241231_lab.xml EX-101.LAB 21967
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bngo-20241231_pre.xml EX-101.PRE 16059
20 EXTRACTED XBRL INSTANCE DOCUMENT ny20039922x1_8k_htm.xml XML 4234
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 25503815
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)